Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil

Detalhes bibliográficos
Autor(a) principal: Florentino, Pilar Tavares Veras
Data de Publicação: 2023
Outros Autores: Silva, Thiago Cerqueira, Carvalho, Luciana Freire de, Alves, Flávia Jôse Oliveira, Oliveira, Vinicius de Araújo, Aguilar, Gislani Mateus Oliveira, Prado, Rodrigo de Sousa, Soranz, Daniel, Pearce, Neil, Boaventura, Viviane S., Werneck, Guilherme Loreiro, Penna, Gerson Oliveira, Barreto, Mauricio Lima, Garcia, Márcio Henrique de Oliveira, Barral Netto, Manoel, Paixão, Enny Santos da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/60841
Resumo: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ). Fundação de Apoio do Estado da Bahia (FAPESB). Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ). Wellcome Trust.
id CRUZ_431299bb201cfb1ce19299bc2361c0ef
oai_identifier_str oai:www.arca.fiocruz.br:icict/60841
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Florentino, Pilar Tavares VerasSilva, Thiago CerqueiraCarvalho, Luciana Freire deAlves, Flávia Jôse OliveiraOliveira, Vinicius de AraújoAguilar, Gislani Mateus OliveiraPrado, Rodrigo de SousaSoranz, DanielPearce, NeilBoaventura, Viviane S.Werneck, Guilherme LoreiroPenna, Gerson OliveiraBarreto, Mauricio LimaGarcia, Márcio Henrique de OliveiraBarral Netto, ManoelPaixão, Enny Santos da2023-10-19T12:53:52Z2023-10-19T12:53:52Z2023FLORENTINO, Pilar Tavares Veras et al. Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil. International Journal of Epidemiology, p. 1-8, 2023.1464-3685https://www.arca.fiocruz.br/handle/icict/6084110.1093/ije/dyad120Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ). Fundação de Apoio do Estado da Bahia (FAPESB). Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ). Wellcome Trust.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para Saúde. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para Saúde. Salvador, BA, Brasil.Secretaria Municipal de Saúde do Rio de Janeiro. Centro de Inteligência Epidemiológica. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Instituto de Estudos em Saúde Coletiva. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para Saúde. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para Saúde. Salvador, BA, Brasil.Secretaria Municipal de Saúde do Rio de Janeiro. Centro de Inteligência Epidemiológica. Rio de Janeiro, RJ, Brasil.Secretaria Municipal de Saúde do Rio de Janeiro. Centro de Inteligência Epidemiológica. Rio de Janeiro, RJ, Brasil.Congresso Nacional. Câmara Legislativa do Distrito Federal. Câmara dos Deputados. Brasília, DF, Brasil.Faculty of Epidemiology and Population Health. London School of Hygiene and Tropical Medicine. London, UK.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Medicina e Saúde Pública de Precisão. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Estudos em Saúde Coletiva. Rio de Janeiro, RJ, Brasil.Universidade de Brasília, Centro de Medicina Tropical. Escola do Governo de Brasília. Fundação Oswaldo Cruz. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para Saúde. Salvador, BA, Brasil.Ministério da Saúde. Secretaria de Saúde. Departamento de Emergências em Saúde Pública. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Medicina e Saúde Pública de Precisão. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Medicina e Saúde Pública de Precisão. Salvador, BA, Brasil.Background: COVID-19 vaccines have been shown to protect pregnant individuals against mild and severe COVID-19 outcomes. However, limited safety data are available for inactivated (CoronaVac) and mRNA (BNT162b2) vaccines during pregnancy regarding their effect on birth outcomes and neonatal mortality, especially in low- and middle-income countries. Methods: We conducted a retrospective population-based cohort study in Rio de Janeiro, Brazil, with 17 513 singleton live births conceived between 15 May 2021 and 23 October 2021. The primary exposure was maternal vaccination with CoronaVac or mRNA BNT162b2 vaccines and sub-analyses were performed by the gestational trimester of the first dose and the number of doses given during pregnancy. The outcomes were pre-term birth (PTB), small for gestational age (SGA), low birthweight (LBW), low Apgar 5 and neonatal death. We used the Cox model to estimate the hazard ratio (HR) with a 95% CI and applied the inverse probability of treatment weights to generate adjusted HRs. Results:We found no significant increase in the risk of PTB (HR: 0.98; 95% CI 0.88, 1.10), SGA (HR: 1.09; 95% CI 0.96, 1.27), LBW (HR: 1.00; 95% CI 0.88, 1.14), low Apgar 5 (HR: 0.81; 95% CI 0.55, 1.22) or neonatal death (HR: 0.88; 95% CI 0.56, 1.48) in women vaccinated with CoronaVac or BNT162b2 vaccines. These findings were consistent across sub-analyses stratified by the gestational trimester of the first dose and the number of doses given during pregnancy. We found mild yet consistent protection against PTB in women who received different vaccine platforms during the third trimester of pregnancy (any vaccines, HR: 0.78; 95% CI 0.63, 0.98; BNT162b2, HR: 0.75; 95% CI 0.59, 0.99). Conclusions: This study provides evidence that COVID-19 vaccination in all trimesters of pregnancy, irrespective of the vaccine type, is safe and does not increase the risk of adverse birth outcomes or neonatal deaths.engOxford University PressGravidezResultados do nascimentoVacinas para o covid-19PregnancyBirth outcomesCOVID-19 vaccinesGravidezComplicações na GravidezVacinas contra COVID-19Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/60841/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALFlorentino, Pilar T. V. - Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality.pdfFlorentino, Pilar T. V. - Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality.pdfapplication/pdf779147https://www.arca.fiocruz.br/bitstream/icict/60841/2/Florentino%2c%20Pilar%20T.%20V.%20-%20Safety%20of%20BNT162b2%20and%20CoronaVac%20during%20pregnancy%20on%20birth%20outcomes%20and%20neonatal%20mortality.pdf2915bd5d2d7e816ecfcc7b615bcaa921MD52icict/608412023-10-19 09:53:53.255oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-10-19T12:53:53Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
title Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
spellingShingle Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
Florentino, Pilar Tavares Veras
Gravidez
Resultados do nascimento
Vacinas para o covid-19
Pregnancy
Birth outcomes
COVID-19 vaccines
Gravidez
Complicações na Gravidez
Vacinas contra COVID-19
title_short Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
title_full Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
title_fullStr Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
title_full_unstemmed Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
title_sort Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil
author Florentino, Pilar Tavares Veras
author_facet Florentino, Pilar Tavares Veras
Silva, Thiago Cerqueira
Carvalho, Luciana Freire de
Alves, Flávia Jôse Oliveira
Oliveira, Vinicius de Araújo
Aguilar, Gislani Mateus Oliveira
Prado, Rodrigo de Sousa
Soranz, Daniel
Pearce, Neil
Boaventura, Viviane S.
Werneck, Guilherme Loreiro
Penna, Gerson Oliveira
Barreto, Mauricio Lima
Garcia, Márcio Henrique de Oliveira
Barral Netto, Manoel
Paixão, Enny Santos da
author_role author
author2 Silva, Thiago Cerqueira
Carvalho, Luciana Freire de
Alves, Flávia Jôse Oliveira
Oliveira, Vinicius de Araújo
Aguilar, Gislani Mateus Oliveira
Prado, Rodrigo de Sousa
Soranz, Daniel
Pearce, Neil
Boaventura, Viviane S.
Werneck, Guilherme Loreiro
Penna, Gerson Oliveira
Barreto, Mauricio Lima
Garcia, Márcio Henrique de Oliveira
Barral Netto, Manoel
Paixão, Enny Santos da
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Florentino, Pilar Tavares Veras
Silva, Thiago Cerqueira
Carvalho, Luciana Freire de
Alves, Flávia Jôse Oliveira
Oliveira, Vinicius de Araújo
Aguilar, Gislani Mateus Oliveira
Prado, Rodrigo de Sousa
Soranz, Daniel
Pearce, Neil
Boaventura, Viviane S.
Werneck, Guilherme Loreiro
Penna, Gerson Oliveira
Barreto, Mauricio Lima
Garcia, Márcio Henrique de Oliveira
Barral Netto, Manoel
Paixão, Enny Santos da
dc.subject.other.en_US.fl_str_mv Gravidez
Resultados do nascimento
Vacinas para o covid-19
topic Gravidez
Resultados do nascimento
Vacinas para o covid-19
Pregnancy
Birth outcomes
COVID-19 vaccines
Gravidez
Complicações na Gravidez
Vacinas contra COVID-19
dc.subject.en.en_US.fl_str_mv Pregnancy
Birth outcomes
COVID-19 vaccines
dc.subject.decs.en_US.fl_str_mv Gravidez
Complicações na Gravidez
Vacinas contra COVID-19
description Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ). Fundação de Apoio do Estado da Bahia (FAPESB). Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ). Wellcome Trust.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-10-19T12:53:52Z
dc.date.available.fl_str_mv 2023-10-19T12:53:52Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FLORENTINO, Pilar Tavares Veras et al. Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil. International Journal of Epidemiology, p. 1-8, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/60841
dc.identifier.issn.en_US.fl_str_mv 1464-3685
dc.identifier.doi.none.fl_str_mv 10.1093/ije/dyad120
identifier_str_mv FLORENTINO, Pilar Tavares Veras et al. Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil. International Journal of Epidemiology, p. 1-8, 2023.
1464-3685
10.1093/ije/dyad120
url https://www.arca.fiocruz.br/handle/icict/60841
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/60841/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/60841/2/Florentino%2c%20Pilar%20T.%20V.%20-%20Safety%20of%20BNT162b2%20and%20CoronaVac%20during%20pregnancy%20on%20birth%20outcomes%20and%20neonatal%20mortality.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
2915bd5d2d7e816ecfcc7b615bcaa921
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009215252332544